Immunwork
OverviewSuggest Edit
Immunwork is a company that researches, develops, and commercializes drugs for cancer treatment with a focus on immunology. It uses a proprietary technology platform to create T-E pharmaceuticals that contain both targeting (T) and effector (E) moieties. The technology can be used for constructing antibody-drug conjugates (ADCs), bispecific antibodies, multivalent antibodies, and other pharmaceutical configurations. The company aims to develop medications for conditions such as cancer, autoimmune diseases, osteoporosis, infectious, and central nervous system diseases, pathological blood clots, and rejection reactions in organ transplantation.
| Type | Private | |
| Founded | 2014 | |
| HQ | TW | Map |
| Website | immunwork.com |
Locations
Latest Updates
| Employees (est.) (Mar 2020) | 12 | |
| Cybersecurity rating | B | More |
Immunwork Financials and Metrics
Summary Metrics
Founding Date | 2014 |
Immunwork Cybersecurity Score
Immunwork Online and Social Media Presence
Immunwork's Trends
Immunwork Frequently Asked Questions
When was Immunwork founded?
Immunwork was founded in 2014.
How many employees does Immunwork have?
Immunwork has 12 employees.
Who are Immunwork competitors?
Competitors of Immunwork include Takeda Oncology, Shanghai Junshi Biosciences and Ethypharm.
Where are Immunwork offices?
Immunwork has an office in.
How many offices does Immunwork have?
Immunwork has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies